Kutschera, M.; Ritschl, V.; Reichardt, B.; Stamm, T.; Kiener, H.; Maier, H.; Reinisch, W.; Benka, B.; Novacek, G.
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. J. Clin. Med. 2022, 11, 5308.
https://doi.org/10.3390/jcm11185308
AMA Style
Kutschera M, Ritschl V, Reichardt B, Stamm T, Kiener H, Maier H, Reinisch W, Benka B, Novacek G.
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. Journal of Clinical Medicine. 2022; 11(18):5308.
https://doi.org/10.3390/jcm11185308
Chicago/Turabian Style
Kutschera, Maximilian, Valentin Ritschl, Berthold Reichardt, Tanja Stamm, Hans Kiener, Harald Maier, Walter Reinisch, Bernhard Benka, and Gottfried Novacek.
2022. "Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study" Journal of Clinical Medicine 11, no. 18: 5308.
https://doi.org/10.3390/jcm11185308
APA Style
Kutschera, M., Ritschl, V., Reichardt, B., Stamm, T., Kiener, H., Maier, H., Reinisch, W., Benka, B., & Novacek, G.
(2022). Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. Journal of Clinical Medicine, 11(18), 5308.
https://doi.org/10.3390/jcm11185308